NewsController
Controller
| path |
/controllers/NewsController.php |
| abs_path |
/var/www/lbofrance.com/docs/wp-content/themes/yagami/controllers/NewsController.php |
Render
| view |
views/news/single.twig |
Datas
array:1 [
"post" => Post {#7023
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:16 [
"_wpml_media_featured" => "1"
"_wpml_media_duplicate" => "1"
"_yoast_wpseo_content_score" => "30"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => ""
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => ""
"_wp_old_date" => array:2 [
0 => "2019-12-18"
1 => "2019-07-19"
]
"_edit_lock" => "1581428469:1"
"_edit_last" => "1"
"_wp_old_slug" => "lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare"
"_last_translation_edit_mode" => "native-editor"
"_wpml_media_has_media" => "1"
]
#___content: """
<p><strong>TRIBVN Healthcare announces a €5m ($5.6m) fundraising campaign financed by LBO France through its Digital Health 2 venture fund. As a major player in digital pathology augmented by artificial intelligence, TRIBVN Healthcare develops a complete imaging software suite combining workstation, diagnostic assistance and telemedicine. </strong></p>\n
<p>This fundraising will enable TRIBVN Healthcare to become the leader in the digital transition of diagnostic and research laboratories in Europe and North America. TRIBVN Healthcare’s innovation enables its customers to be more efficient and more secure in their practices. These are today the major challenges of diagnosis in the context of increasingly personalized and data driven medicine, particularly in oncology.</p>\n
<p>In addition to accelerating international business development, the fundraising will enhance CaloPix and TeleSlide solutions by integrating the latest technological innovations from the Cloud and AI. With its experience and roots in the largest clinical and research institutions in Europe and Canada, TRIBVN Healthcare will continue to work and ensure that this digital transformation takes place with physicians and for the benefit of patients, thus creating real and lasting value.</p>\n
<p><strong>Jean-François Pomerol, CEO of TRIBVN Healthcare</strong>, explains:<em> “I am very excited that LBO France is supporting us in the next phase of TRIBVN Healthcare’s development. The professionalism and experience of the venture health team is an undeniable recognition of our know-how and a strong commitment in our ability to transform cellular diagnostics at an international scale. The funding will allow us to increase the added value of our solutions and provide effective solutions to the problems faced by laboratories.” </em></p>\n
<p><strong>Sébastien Woynar, Investment Director</strong> at LBO France, adds: <em>“Artificial intelligence enhanced digital pathology is revolutionizing pathology and several medical specialties, such as oncology. TRIBVN Healthcare has a remarkable understanding of the field of pathology and a deep product portfolio, key success factors to build a global footprint. This support strengthens TRIBVN Healthcare’s ability to be, on a global scale, the privileged partner of pathology laboratories and research centers.” </em></p>\n
<p><strong>About TRIBVN Healthcare:</strong></p>\n
<p>TRIBVN Healthcare develops software solutions for digital pathology. Innovative and validated, they allow the management, analysis and sharing of cellular images both for diagnostic laboratories and pharmaceutical & biotech manufacturers.</p>\n
<p>In the field of image analysis, our solutions are based on the latest innovations in terms of artificial intelligence, notably deep and machine learning algorithms. These tools support physicians and researchers in their diagnostic decision-making and scientific evaluation for the sake of patients.</p>\n
<p>In the field of sharing, our solutions implement full web tools to support our customers in their telepathology, teaching or multi-centric clinical validation activities.</p>\n
<p>Find out more: <a href="http://www.tribvn-hc.com">www.tribvn-hc.com</a> – <a href="http://www.teleslide.com">www.teleslide.com </a></p>\n
<p>Contact: Jean-François Pomerol – CEO – jfpomerol@tribvn-hc.com</p>\n
<p>Media Contact: Pauline Baldo, Marketing & Communication manager – pbaldo@tribvn-hc.com – +33 1 55 58 05 35</p>\n
<p><strong> About LBO France: </strong></p>\n
<p>As a key player in private equity with €4bn of capital under management, LBO France is an independent company that has been supporting European companies in their growth for more than 30 years. Its investment strategy is built on 4 distinct segments managed by dedicated teams: (i) Mid Cap Buyout through the White Knight funds and Small Cap Buyout through the Hexagone/Small Caps Opportunities funds, (ii) Venture Capital through the SISA/Digital Health funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100% owned by its management and employs nearly 60 professionals.</p>\n
<p>Find out more: <a href="http://www.lbofrance.com">www.lbofrance.com </a></p>\n
<p>Contact: Sébastien Woynar, Investment Director – sebastien.woynar@lbofrance.com</p>\n
<p><strong>Media Contact: </strong></p>\n
<p>Agence Shan</p>\n
<p>Léa Schultz – + 33 1 42 86 82 41 – lea.schultz@shan.fr</p>\n
<p>Laetitia Hottinguer – + 33 1 44 50 58 78 – laetitia.hottinguer@shan.fr</p>\n
<p> </p>\n
<p> </p>\n
<p><a href="https://www.lbofrance.com/wp-content/uploads/2019/12/cp-ldf-thc-final-en.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a></p>\n
"""
#_permalink: "https://www.lbofrance.com/en/lbo-france-announces-its-investment-in-tribvn-healthcare/"
#_next: []
#_prev: []
#_css_class: null
+id: 2132
+ID: 2132
+post_author: "1"
+post_content: """
<strong>TRIBVN Healthcare announces a €5m ($5.6m) fundraising campaign financed by LBO France through its Digital Health 2 venture fund. As a major player in digital pathology augmented by artificial intelligence, TRIBVN Healthcare develops a complete imaging software suite combining workstation, diagnostic assistance and telemedicine. </strong>\r\n
\r\n
This fundraising will enable TRIBVN Healthcare to become the leader in the digital transition of diagnostic and research laboratories in Europe and North America. TRIBVN Healthcare's innovation enables its customers to be more efficient and more secure in their practices. These are today the major challenges of diagnosis in the context of increasingly personalized and data driven medicine, particularly in oncology.\r\n
\r\n
In addition to accelerating international business development, the fundraising will enhance CaloPix and TeleSlide solutions by integrating the latest technological innovations from the Cloud and AI. With its experience and roots in the largest clinical and research institutions in Europe and Canada, TRIBVN Healthcare will continue to work and ensure that this digital transformation takes place with physicians and for the benefit of patients, thus creating real and lasting value.\r\n
\r\n
<strong>Jean-François Pomerol, CEO of TRIBVN Healthcare</strong>, explains:<em> "I am very excited that LBO France is supporting us in the next phase of TRIBVN Healthcare's development. The professionalism and experience of the venture health team is an undeniable recognition of our know-how and a strong commitment in our ability to transform cellular diagnostics at an international scale. The funding will allow us to increase the added value of our solutions and provide effective solutions to the problems faced by laboratories." </em>\r\n
\r\n
<strong>Sébastien Woynar, Investment Director</strong> at LBO France, adds: <em>“Artificial intelligence enhanced digital pathology is revolutionizing pathology and several medical specialties, such as oncology. TRIBVN Healthcare has a remarkable understanding of the field of pathology and a deep product portfolio, key success factors to build a global footprint. This support strengthens TRIBVN Healthcare's ability to be, on a global scale, the privileged partner of pathology laboratories and research centers.” </em>\r\n
\r\n
<strong>About TRIBVN Healthcare:</strong>\r\n
\r\n
TRIBVN Healthcare develops software solutions for digital pathology. Innovative and validated, they allow the management, analysis and sharing of cellular images both for diagnostic laboratories and pharmaceutical & biotech manufacturers.\r\n
\r\n
In the field of image analysis, our solutions are based on the latest innovations in terms of artificial intelligence, notably deep and machine learning algorithms. These tools support physicians and researchers in their diagnostic decision-making and scientific evaluation for the sake of patients.\r\n
\r\n
In the field of sharing, our solutions implement full web tools to support our customers in their telepathology, teaching or multi-centric clinical validation activities.\r\n
\r\n
Find out more: <a href="http://www.tribvn-hc.com">www.tribvn-hc.com</a> - <a href="http://www.teleslide.com">www.teleslide.com </a>\r\n
\r\n
Contact: Jean-François Pomerol - CEO - jfpomerol@tribvn-hc.com\r\n
\r\n
Media Contact: Pauline Baldo, Marketing & Communication manager – pbaldo@tribvn-hc.com - +33 1 55 58 05 35\r\n
\r\n
<strong> About LBO France: </strong>\r\n
\r\n
As a key player in private equity with €4bn of capital under management, LBO France is an independent company that has been supporting European companies in their growth for more than 30 years. Its investment strategy is built on 4 distinct segments managed by dedicated teams: (i) Mid Cap Buyout through the White Knight funds and Small Cap Buyout through the Hexagone/Small Caps Opportunities funds, (ii) Venture Capital through the SISA/Digital Health funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100% owned by its management and employs nearly 60 professionals.\r\n
\r\n
Find out more: <a href="http://www.lbofrance.com">www.lbofrance.com </a>\r\n
\r\n
Contact: Sébastien Woynar, Investment Director - sebastien.woynar@lbofrance.com\r\n
\r\n
<strong>Media Contact: </strong>\r\n
\r\n
Agence Shan\r\n
\r\n
Léa Schultz - + 33 1 42 86 82 41 – lea.schultz@shan.fr\r\n
\r\n
Laetitia Hottinguer - + 33 1 44 50 58 78 – laetitia.hottinguer@shan.fr\r\n
\r\n
\r\n
\r\n
\r\n
\r\n
<a href="https://www.lbofrance.com/wp-content/uploads/2019/12/cp-ldf-thc-final-en.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
"""
+post_date: "2019-07-16 13:42:56"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "LBO France announces its investment in TRIBVN HEALTHCARE"
+post_type: "post"
+slug: "lbo-france-announces-its-investment-in-tribvn-healthcare"
#__type: null
+"_wpml_media_featured": "1"
+"_wpml_media_duplicate": "1"
+"_yoast_wpseo_content_score": "30"
+"banner": ""
+"_banner": "field_5d0b8f67a8a14"
+"linkedin": ""
+"_linkedin": "field_5d0b8fa0a8a15"
+"fichier": ""
+"_fichier": "field_5d0b8faba8a16"
+"_yoast_wpseo_primary_category": ""
+"_wp_old_date": array:2 [
0 => "2019-12-18"
1 => "2019-07-19"
]
+"_edit_lock": "1581428469:1"
+"_edit_last": "1"
+"_wp_old_slug": "lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare"
+"_last_translation_edit_mode": "native-editor"
+"_wpml_media_has_media": "1"
+"post_date_gmt": "2019-07-16 11:42:56"
+"comment_status": "open"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "lbo-france-announces-its-investment-in-tribvn-healthcare"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2020-02-11 14:43:29"
+"post_modified_gmt": "2020-02-11 13:43:29"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare/"
+"menu_order": 0
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"status": "publish"
+"partial_banner_title": false
+"partial_banner_image": false
}
]
TimberPost
ID:
2132
post_type:
post
slug:
lbo-france-announces-its-investment-in-tribvn-healthcare
post_name:
lbo-france-announces-its-investment-in-tribvn-healthcare
post_title:
LBO France announces its investment in TRIBVN HEALTHCARE
array:54 [
"ImageClass" => "Timber\Image"
"PostClass" => "Timber\Post"
"TermClass" => "Timber\Term"
"object_type" => "post"
"custom" => array:16 [
"_wpml_media_featured" => "1"
"_wpml_media_duplicate" => "1"
"_yoast_wpseo_content_score" => "30"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => ""
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => ""
"_wp_old_date" => array:2 [
0 => "2019-12-18"
1 => "2019-07-19"
]
"_edit_lock" => "1581428469:1"
"_edit_last" => "1"
"_wp_old_slug" => "lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare"
"_last_translation_edit_mode" => "native-editor"
"_wpml_media_has_media" => "1"
]
"\x00*\x00___content" => null
"\x00*\x00_permalink" => null
"\x00*\x00_next" => []
"\x00*\x00_prev" => []
"\x00*\x00_css_class" => null
"id" => 2132
"ID" => 2132
"post_author" => "1"
"post_content" => """
<strong>TRIBVN Healthcare announces a €5m ($5.6m) fundraising campaign financed by LBO France through its Digital Health 2 venture fund. As a major player in digital pathology augmented by artificial intelligence, TRIBVN Healthcare develops a complete imaging software suite combining workstation, diagnostic assistance and telemedicine. </strong>\r\n
\r\n
This fundraising will enable TRIBVN Healthcare to become the leader in the digital transition of diagnostic and research laboratories in Europe and North America. TRIBVN Healthcare's innovation enables its customers to be more efficient and more secure in their practices. These are today the major challenges of diagnosis in the context of increasingly personalized and data driven medicine, particularly in oncology.\r\n
\r\n
In addition to accelerating international business development, the fundraising will enhance CaloPix and TeleSlide solutions by integrating the latest technological innovations from the Cloud and AI. With its experience and roots in the largest clinical and research institutions in Europe and Canada, TRIBVN Healthcare will continue to work and ensure that this digital transformation takes place with physicians and for the benefit of patients, thus creating real and lasting value.\r\n
\r\n
<strong>Jean-François Pomerol, CEO of TRIBVN Healthcare</strong>, explains:<em> "I am very excited that LBO France is supporting us in the next phase of TRIBVN Healthcare's development. The professionalism and experience of the venture health team is an undeniable recognition of our know-how and a strong commitment in our ability to transform cellular diagnostics at an international scale. The funding will allow us to increase the added value of our solutions and provide effective solutions to the problems faced by laboratories." </em>\r\n
\r\n
<strong>Sébastien Woynar, Investment Director</strong> at LBO France, adds: <em>“Artificial intelligence enhanced digital pathology is revolutionizing pathology and several medical specialties, such as oncology. TRIBVN Healthcare has a remarkable understanding of the field of pathology and a deep product portfolio, key success factors to build a global footprint. This support strengthens TRIBVN Healthcare's ability to be, on a global scale, the privileged partner of pathology laboratories and research centers.” </em>\r\n
\r\n
<strong>About TRIBVN Healthcare:</strong>\r\n
\r\n
TRIBVN Healthcare develops software solutions for digital pathology. Innovative and validated, they allow the management, analysis and sharing of cellular images both for diagnostic laboratories and pharmaceutical & biotech manufacturers.\r\n
\r\n
In the field of image analysis, our solutions are based on the latest innovations in terms of artificial intelligence, notably deep and machine learning algorithms. These tools support physicians and researchers in their diagnostic decision-making and scientific evaluation for the sake of patients.\r\n
\r\n
In the field of sharing, our solutions implement full web tools to support our customers in their telepathology, teaching or multi-centric clinical validation activities.\r\n
\r\n
Find out more: <a href="http://www.tribvn-hc.com">www.tribvn-hc.com</a> - <a href="http://www.teleslide.com">www.teleslide.com </a>\r\n
\r\n
Contact: Jean-François Pomerol - CEO - jfpomerol@tribvn-hc.com\r\n
\r\n
Media Contact: Pauline Baldo, Marketing & Communication manager – pbaldo@tribvn-hc.com - +33 1 55 58 05 35\r\n
\r\n
<strong> About LBO France: </strong>\r\n
\r\n
As a key player in private equity with €4bn of capital under management, LBO France is an independent company that has been supporting European companies in their growth for more than 30 years. Its investment strategy is built on 4 distinct segments managed by dedicated teams: (i) Mid Cap Buyout through the White Knight funds and Small Cap Buyout through the Hexagone/Small Caps Opportunities funds, (ii) Venture Capital through the SISA/Digital Health funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100% owned by its management and employs nearly 60 professionals.\r\n
\r\n
Find out more: <a href="http://www.lbofrance.com">www.lbofrance.com </a>\r\n
\r\n
Contact: Sébastien Woynar, Investment Director - sebastien.woynar@lbofrance.com\r\n
\r\n
<strong>Media Contact: </strong>\r\n
\r\n
Agence Shan\r\n
\r\n
Léa Schultz - + 33 1 42 86 82 41 – lea.schultz@shan.fr\r\n
\r\n
Laetitia Hottinguer - + 33 1 44 50 58 78 – laetitia.hottinguer@shan.fr\r\n
\r\n
\r\n
\r\n
\r\n
\r\n
<a href="https://www.lbofrance.com/wp-content/uploads/2019/12/cp-ldf-thc-final-en.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
"""
"post_date" => "2019-07-16 13:42:56"
"post_excerpt" => ""
"post_parent" => 0
"post_status" => "publish"
"post_title" => "LBO France announces its investment in TRIBVN HEALTHCARE"
"post_type" => "post"
"slug" => "lbo-france-announces-its-investment-in-tribvn-healthcare"
"\x00*\x00__type" => null
"_wpml_media_featured" => "1"
"_wpml_media_duplicate" => "1"
"_yoast_wpseo_content_score" => "30"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => ""
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => ""
"_wp_old_date" => array:2 [
0 => "2019-12-18"
1 => "2019-07-19"
]
"_edit_lock" => "1581428469:1"
"_edit_last" => "1"
"_wp_old_slug" => "lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare"
"_last_translation_edit_mode" => "native-editor"
"_wpml_media_has_media" => "1"
"post_date_gmt" => "2019-07-16 11:42:56"
"comment_status" => "open"
"ping_status" => "closed"
"post_password" => ""
"post_name" => "lbo-france-announces-its-investment-in-tribvn-healthcare"
"to_ping" => ""
"pinged" => ""
"post_modified" => "2020-02-11 14:43:29"
"post_modified_gmt" => "2020-02-11 13:43:29"
"post_content_filtered" => ""
"guid" => "https://www.lbofrance.com/lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare/"
"menu_order" => 0
"post_mime_type" => ""
"comment_count" => "0"
"filter" => "raw"
"status" => "publish"
]
Timber Context
Base Context
array:10 [
"http_host" => "https://www.lbofrance.com"
"wp_title" => "LBO France announces its investment in TRIBVN HEALTHCARE - LBO France"
"body_class" => "post-template-default single single-post postid-2132 single-format-standard"
"site" => Site {#7018
+admin_email: "admin@adveris.fr"
+blogname: null
+charset: "UTF-8"
+description: ""
+id: null
+language: "en_US"
+multisite: false
+name: "LBO France"
+pingback_url: "https://www.lbofrance.com/xmlrpc.php"
+siteurl: null
+theme: Theme {#7031
+name: "Yagami"
+version: ""
+parent: false
+parent_slug: null
+slug: "yagami"
+uri: "https://www.lbofrance.com/wp-content/themes/yagami"
-theme: WP_Theme {#7029
+update: false
-theme_root: "/var/www/lbofrance.com/docs/wp-content/themes"
-headers: array:14 [
"Name" => "Yagami"
"ThemeURI" => ""
"Description" => "Custom starter to build wordpress theme from scratch"
"Author" => "Kévin Vacherot"
"AuthorURI" => "https://www.linkedin.com/in/k%C3%A9vin-vacherot-b9a004a2/"
"Version" => ""
"Template" => ""
"Status" => ""
"Tags" => "yagami, blank"
"TextDomain" => "Yagami"
"DomainPath" => ""
"RequiresWP" => ""
"RequiresPHP" => ""
"UpdateURI" => ""
]
-headers_sanitized: array:2 [
"Name" => "Yagami"
"Version" => ""
]
-block_theme: false
-name_translated: null
-errors: null
-stylesheet: "yagami"
-template: "yagami"
-parent: null
-theme_root_uri: "https://www.lbofrance.com/wp-content/themes"
-textdomain_loaded: null
-cache_hash: "37a7699c69410d0bf18f875580b71453"
}
+id: null
+ID: null
+object_type: null
}
+title: "LBO France"
+url: "https://www.lbofrance.com/en/"
+home_url: "https://www.lbofrance.com/en/"
+site_url: "https://www.lbofrance.com"
+rdf: "https://www.lbofrance.com/en/feed/rdf/"
+rss: "https://www.lbofrance.com/en/feed/rss/"
+rss2: "https://www.lbofrance.com/en/feed/"
+atom: "https://www.lbofrance.com/en/feed/atom/"
+ID: null
+object_type: null
+"pingback": "https://www.lbofrance.com/xmlrpc.php"
}
"request" => Request {#7030
+post: []
+get: []
+id: null
+ID: null
+object_type: null
}
"user" => false
"theme" => Theme {#7031}
"posts" => PostQuery {#7033
+found_posts: 1
#userQuery: false
#queryIterator: QueryIterator {#7034
-_query: WP_Query {#4911
+query: array:2 [
"page" => ""
"name" => "lbo-france-announces-its-investment-in-tribvn-healthcare"
]
+query_vars: array:67 [
"page" => 0
"error" => ""
"m" => ""
"p" => 2132
"post_parent" => ""
"subpost" => ""
"subpost_id" => ""
"attachment" => ""
"attachment_id" => 0
"pagename" => ""
"page_id" => ""
"second" => ""
"minute" => ""
"hour" => ""
"day" => 0
"monthnum" => 0
"year" => 0
"w" => 0
"category_name" => ""
"tag" => ""
"cat" => ""
"tag_id" => ""
"author" => ""
"author_name" => ""
"feed" => ""
"tb" => ""
"paged" => 0
"meta_key" => ""
"meta_value" => ""
"preview" => ""
"s" => ""
"sentence" => ""
"title" => ""
"fields" => ""
"menu_order" => ""
"embed" => ""
"category__in" => []
"category__not_in" => []
"category__and" => []
"post__in" => []
"post__not_in" => []
"post_name__in" => []
"tag__in" => []
"tag__not_in" => []
"tag__and" => []
"tag_slug__in" => []
"tag_slug__and" => []
"post_parent__in" => []
"post_parent__not_in" => []
"author__in" => []
"author__not_in" => []
"search_columns" => []
"meta_query" => []
"name" => ""
"ignore_sticky_posts" => false
"suppress_filters" => false
"cache_results" => true
"update_post_term_cache" => true
"update_menu_item_cache" => false
"lazy_load_term_meta" => true
"update_post_meta_cache" => true
"post_type" => ""
"posts_per_page" => 9
"nopaging" => false
"comments_per_page" => "50"
"no_found_rows" => false
"order" => "DESC"
]
+tax_query: null
+meta_query: WP_Meta_Query {#7000
+queries: []
+relation: null
+meta_table: null
+meta_id_column: null
+primary_table: null
+primary_id_column: null
#table_aliases: []
#clauses: []
#has_or_relation: false
}
+date_query: false
+queried_object: WP_Post {#6992
+ID: 2132
+post_author: "1"
+post_date: "2019-07-16 13:42:56"
+post_date_gmt: "2019-07-16 11:42:56"
+post_content: """
<strong>TRIBVN Healthcare announces a €5m ($5.6m) fundraising campaign financed by LBO France through its Digital Health 2 venture fund. As a major player in digital pathology augmented by artificial intelligence, TRIBVN Healthcare develops a complete imaging software suite combining workstation, diagnostic assistance and telemedicine. </strong>\r\n
\r\n
This fundraising will enable TRIBVN Healthcare to become the leader in the digital transition of diagnostic and research laboratories in Europe and North America. TRIBVN Healthcare's innovation enables its customers to be more efficient and more secure in their practices. These are today the major challenges of diagnosis in the context of increasingly personalized and data driven medicine, particularly in oncology.\r\n
\r\n
In addition to accelerating international business development, the fundraising will enhance CaloPix and TeleSlide solutions by integrating the latest technological innovations from the Cloud and AI. With its experience and roots in the largest clinical and research institutions in Europe and Canada, TRIBVN Healthcare will continue to work and ensure that this digital transformation takes place with physicians and for the benefit of patients, thus creating real and lasting value.\r\n
\r\n
<strong>Jean-François Pomerol, CEO of TRIBVN Healthcare</strong>, explains:<em> "I am very excited that LBO France is supporting us in the next phase of TRIBVN Healthcare's development. The professionalism and experience of the venture health team is an undeniable recognition of our know-how and a strong commitment in our ability to transform cellular diagnostics at an international scale. The funding will allow us to increase the added value of our solutions and provide effective solutions to the problems faced by laboratories." </em>\r\n
\r\n
<strong>Sébastien Woynar, Investment Director</strong> at LBO France, adds: <em>“Artificial intelligence enhanced digital pathology is revolutionizing pathology and several medical specialties, such as oncology. TRIBVN Healthcare has a remarkable understanding of the field of pathology and a deep product portfolio, key success factors to build a global footprint. This support strengthens TRIBVN Healthcare's ability to be, on a global scale, the privileged partner of pathology laboratories and research centers.” </em>\r\n
\r\n
<strong>About TRIBVN Healthcare:</strong>\r\n
\r\n
TRIBVN Healthcare develops software solutions for digital pathology. Innovative and validated, they allow the management, analysis and sharing of cellular images both for diagnostic laboratories and pharmaceutical & biotech manufacturers.\r\n
\r\n
In the field of image analysis, our solutions are based on the latest innovations in terms of artificial intelligence, notably deep and machine learning algorithms. These tools support physicians and researchers in their diagnostic decision-making and scientific evaluation for the sake of patients.\r\n
\r\n
In the field of sharing, our solutions implement full web tools to support our customers in their telepathology, teaching or multi-centric clinical validation activities.\r\n
\r\n
Find out more: <a href="http://www.tribvn-hc.com">www.tribvn-hc.com</a> - <a href="http://www.teleslide.com">www.teleslide.com </a>\r\n
\r\n
Contact: Jean-François Pomerol - CEO - jfpomerol@tribvn-hc.com\r\n
\r\n
Media Contact: Pauline Baldo, Marketing & Communication manager – pbaldo@tribvn-hc.com - +33 1 55 58 05 35\r\n
\r\n
<strong> About LBO France: </strong>\r\n
\r\n
As a key player in private equity with €4bn of capital under management, LBO France is an independent company that has been supporting European companies in their growth for more than 30 years. Its investment strategy is built on 4 distinct segments managed by dedicated teams: (i) Mid Cap Buyout through the White Knight funds and Small Cap Buyout through the Hexagone/Small Caps Opportunities funds, (ii) Venture Capital through the SISA/Digital Health funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100% owned by its management and employs nearly 60 professionals.\r\n
\r\n
Find out more: <a href="http://www.lbofrance.com">www.lbofrance.com </a>\r\n
\r\n
Contact: Sébastien Woynar, Investment Director - sebastien.woynar@lbofrance.com\r\n
\r\n
<strong>Media Contact: </strong>\r\n
\r\n
Agence Shan\r\n
\r\n
Léa Schultz - + 33 1 42 86 82 41 – lea.schultz@shan.fr\r\n
\r\n
Laetitia Hottinguer - + 33 1 44 50 58 78 – laetitia.hottinguer@shan.fr\r\n
\r\n
\r\n
\r\n
\r\n
\r\n
<a href="https://www.lbofrance.com/wp-content/uploads/2019/12/cp-ldf-thc-final-en.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
"""
+post_title: "LBO France announces its investment in TRIBVN HEALTHCARE"
+post_excerpt: ""
+post_status: "publish"
+comment_status: "open"
+ping_status: "closed"
+post_password: ""
+post_name: "lbo-france-announces-its-investment-in-tribvn-healthcare"
+to_ping: ""
+pinged: ""
+post_modified: "2020-02-11 14:43:29"
+post_modified_gmt: "2020-02-11 13:43:29"
+post_content_filtered: ""
+post_parent: 0
+guid: "https://www.lbofrance.com/lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare/"
+menu_order: 0
+post_type: "post"
+post_mime_type: ""
+comment_count: "0"
+filter: "raw"
+"status": "publish"
+"id": 2132
+"slug": "lbo-france-announces-its-investment-in-tribvn-healthcare"
+"custom": array:16 [
"_wpml_media_featured" => "1"
"_wpml_media_duplicate" => "1"
"_yoast_wpseo_content_score" => "30"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => ""
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => ""
"_wp_old_date" => array:2 [
0 => "2019-12-18"
1 => "2019-07-19"
]
"_edit_lock" => "1581428469:1"
"_edit_last" => "1"
"_wp_old_slug" => "lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare"
"_last_translation_edit_mode" => "native-editor"
"_wpml_media_has_media" => "1"
]
}
+queried_object_id: 2132
+request: """
\n
\t\t\tSELECT lbo_posts.*\n
\t\t\tFROM lbo_posts JOIN lbo_icl_translations wpml_translations\n
\t\t\t\t\t\t\tON lbo_posts.ID = wpml_translations.element_id\n
\t\t\t\t\t\t\t\tAND wpml_translations.element_type = CONCAT('post_', lbo_posts.post_type) \n
\t\t\tWHERE 1=1 AND lbo_posts.ID = 2132 AND lbo_posts.post_type = 'post' AND ( ( ( wpml_translations.language_code = 'en' OR 0 ) AND lbo_posts.post_type IN ('post','page','attachment','wp_block','wp_template','wp_template_part','wp_navigation','members','investments' ) ) OR lbo_posts.post_type NOT IN ('post','page','attachment','wp_block','wp_template','wp_template_part','wp_navigation','members','investments' ) )\n
\t\t\t\n
\t\t\tORDER BY lbo_posts.post_date DESC\n
\t\t\t\n
\t\t
"""
+posts: & array:1 [
0 => WP_Post {#6992}
]
+post_count: 1
+current_post: -1
+in_the_loop: false
+post: WP_Post {#6992}
+comment_count: 0
+current_comment: -1
+found_posts: 1
+max_num_pages: 0
+max_num_comment_pages: 0
+is_single: true
+is_preview: false
+is_page: false
+is_archive: false
+is_date: false
+is_year: false
+is_month: false
+is_day: false
+is_time: false
+is_author: false
+is_category: false
+is_tag: false
+is_tax: false
+is_search: false
+is_feed: false
+is_comment_feed: false
+is_trackback: false
+is_home: false
+is_privacy_policy: false
+is_404: false
+is_embed: false
+is_paged: false
+is_admin: false
+is_attachment: false
+is_singular: true
+is_robots: false
+is_favicon: false
+is_posts_page: false
+is_post_type_archive: false
-query_vars_hash: "1421ed999af5d57e143dc76076e0290f"
-query_vars_changed: true
+thumbnails_cached: false
#allow_query_attachment_by_filename: false
-stopwords: null
-compat_fields: array:2 [
0 => "query_vars_hash"
1 => "query_vars_changed"
]
-compat_methods: array:2 [
0 => "init_query_flags"
1 => "parse_tax_query"
]
}
-_posts_class: "\Timber\Post"
}
#pagination: null
flag::STD_PROP_LIST: false
flag::ARRAY_AS_PROPS: false
iteratorClass: "Timber\PostsIterator"
storage: array:1 [
0 => Post {#7036
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:16 [
"_wpml_media_featured" => "1"
"_wpml_media_duplicate" => "1"
"_yoast_wpseo_content_score" => "30"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => ""
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => ""
"_wp_old_date" => array:2 [
0 => "2019-12-18"
1 => "2019-07-19"
]
"_edit_lock" => "1581428469:1"
"_edit_last" => "1"
"_wp_old_slug" => "lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare"
"_last_translation_edit_mode" => "native-editor"
"_wpml_media_has_media" => "1"
]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2132
+ID: 2132
+post_author: "1"
+post_content: """
<strong>TRIBVN Healthcare announces a €5m ($5.6m) fundraising campaign financed by LBO France through its Digital Health 2 venture fund. As a major player in digital pathology augmented by artificial intelligence, TRIBVN Healthcare develops a complete imaging software suite combining workstation, diagnostic assistance and telemedicine. </strong>\r\n
\r\n
This fundraising will enable TRIBVN Healthcare to become the leader in the digital transition of diagnostic and research laboratories in Europe and North America. TRIBVN Healthcare's innovation enables its customers to be more efficient and more secure in their practices. These are today the major challenges of diagnosis in the context of increasingly personalized and data driven medicine, particularly in oncology.\r\n
\r\n
In addition to accelerating international business development, the fundraising will enhance CaloPix and TeleSlide solutions by integrating the latest technological innovations from the Cloud and AI. With its experience and roots in the largest clinical and research institutions in Europe and Canada, TRIBVN Healthcare will continue to work and ensure that this digital transformation takes place with physicians and for the benefit of patients, thus creating real and lasting value.\r\n
\r\n
<strong>Jean-François Pomerol, CEO of TRIBVN Healthcare</strong>, explains:<em> "I am very excited that LBO France is supporting us in the next phase of TRIBVN Healthcare's development. The professionalism and experience of the venture health team is an undeniable recognition of our know-how and a strong commitment in our ability to transform cellular diagnostics at an international scale. The funding will allow us to increase the added value of our solutions and provide effective solutions to the problems faced by laboratories." </em>\r\n
\r\n
<strong>Sébastien Woynar, Investment Director</strong> at LBO France, adds: <em>“Artificial intelligence enhanced digital pathology is revolutionizing pathology and several medical specialties, such as oncology. TRIBVN Healthcare has a remarkable understanding of the field of pathology and a deep product portfolio, key success factors to build a global footprint. This support strengthens TRIBVN Healthcare's ability to be, on a global scale, the privileged partner of pathology laboratories and research centers.” </em>\r\n
\r\n
<strong>About TRIBVN Healthcare:</strong>\r\n
\r\n
TRIBVN Healthcare develops software solutions for digital pathology. Innovative and validated, they allow the management, analysis and sharing of cellular images both for diagnostic laboratories and pharmaceutical & biotech manufacturers.\r\n
\r\n
In the field of image analysis, our solutions are based on the latest innovations in terms of artificial intelligence, notably deep and machine learning algorithms. These tools support physicians and researchers in their diagnostic decision-making and scientific evaluation for the sake of patients.\r\n
\r\n
In the field of sharing, our solutions implement full web tools to support our customers in their telepathology, teaching or multi-centric clinical validation activities.\r\n
\r\n
Find out more: <a href="http://www.tribvn-hc.com">www.tribvn-hc.com</a> - <a href="http://www.teleslide.com">www.teleslide.com </a>\r\n
\r\n
Contact: Jean-François Pomerol - CEO - jfpomerol@tribvn-hc.com\r\n
\r\n
Media Contact: Pauline Baldo, Marketing & Communication manager – pbaldo@tribvn-hc.com - +33 1 55 58 05 35\r\n
\r\n
<strong> About LBO France: </strong>\r\n
\r\n
As a key player in private equity with €4bn of capital under management, LBO France is an independent company that has been supporting European companies in their growth for more than 30 years. Its investment strategy is built on 4 distinct segments managed by dedicated teams: (i) Mid Cap Buyout through the White Knight funds and Small Cap Buyout through the Hexagone/Small Caps Opportunities funds, (ii) Venture Capital through the SISA/Digital Health funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100% owned by its management and employs nearly 60 professionals.\r\n
\r\n
Find out more: <a href="http://www.lbofrance.com">www.lbofrance.com </a>\r\n
\r\n
Contact: Sébastien Woynar, Investment Director - sebastien.woynar@lbofrance.com\r\n
\r\n
<strong>Media Contact: </strong>\r\n
\r\n
Agence Shan\r\n
\r\n
Léa Schultz - + 33 1 42 86 82 41 – lea.schultz@shan.fr\r\n
\r\n
Laetitia Hottinguer - + 33 1 44 50 58 78 – laetitia.hottinguer@shan.fr\r\n
\r\n
\r\n
\r\n
\r\n
\r\n
<a href="https://www.lbofrance.com/wp-content/uploads/2019/12/cp-ldf-thc-final-en.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
"""
+post_date: "2019-07-16 13:42:56"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "LBO France announces its investment in TRIBVN HEALTHCARE"
+post_type: "post"
+slug: "lbo-france-announces-its-investment-in-tribvn-healthcare"
#__type: null
+"_wpml_media_featured": "1"
+"_wpml_media_duplicate": "1"
+"_yoast_wpseo_content_score": "30"
+"banner": ""
+"_banner": "field_5d0b8f67a8a14"
+"linkedin": ""
+"_linkedin": "field_5d0b8fa0a8a15"
+"fichier": ""
+"_fichier": "field_5d0b8faba8a16"
+"_yoast_wpseo_primary_category": ""
+"_wp_old_date": array:2 [
0 => "2019-12-18"
1 => "2019-07-19"
]
+"_edit_lock": "1581428469:1"
+"_edit_last": "1"
+"_wp_old_slug": "lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare"
+"_last_translation_edit_mode": "native-editor"
+"_wpml_media_has_media": "1"
+"post_date_gmt": "2019-07-16 11:42:56"
+"comment_status": "open"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "lbo-france-announces-its-investment-in-tribvn-healthcare"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2020-02-11 14:43:29"
+"post_modified_gmt": "2020-02-11 13:43:29"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare/"
+"menu_order": 0
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"status": "publish"
}
]
}
"wp_head" => FunctionWrapper {#7035
-_class: null
-_function: "wp_head"
-_args: []
-_use_ob: false
}
"wp_footer" => FunctionWrapper {#7041
-_class: null
-_function: "wp_footer"
-_args: []
-_use_ob: false
}
]
Custom Context
array:24 [
"timber" => TimberManager {#4944
-configuration: array:3 [
"timber" => array:2 [
"views_location" => "/views"
"links" => array:2 [
"archives" => array:1 [
"news" => "post"
]
"pages" => array:1 [
"page_exemple" => 2
]
]
]
"wordpress" => array:7 [
"show_admin_bar" => false
"clear_head_for_yoast" => true
"query_vars" => array:5 [
0 => "custom_var_1"
1 => "custom_var_2"
2 => "custom_var_3"
3 => "custom_var_4"
4 => "custom_var_5"
]
"theme_supports" => array:5 [
0 => "title-tag"
1 => "post-formats"
2 => "post-thumbnails"
3 => "menus"
4 => array:2 [
"support" => "html5"
"arg" => array:5 [
0 => "comment-list"
1 => "comment-form"
2 => "search-form"
3 => "gallery"
4 => "caption"
]
]
]
"menus" => array:3 [
"primary" => "Menu Principal"
"secondary" => "Menu Secondaire"
"footer" => "Menu Footer"
]
"remove_action" => array:1 [
"wp_head" => "wp_generator"
]
"images_sizes" => array:1 [
"square_sm" => array:3 [
"w" => 300
"h" => 300
"crop" => array:2 [
0 => "center"
1 => "center"
]
]
]
]
"acf" => array:2 [
"google_map_api_key" => "AIzaSyDGF98psyVSiyiVhFovqfhMDrGJ-Ls2Uoc"
"options" => array:1 [
"options_page" => array:2 [
"page" => array:4 [
"page_title" => "Option"
"menu_title" => "Options"
"menu_slug" => "options"
"capability" => "edit_posts"
]
"sub_menus" => array:4 [
0 => array:2 [ …2]
1 => array:2 [ …2]
2 => array:2 [ …2]
3 => array:2 [ …2]
]
]
]
]
]
}
"services" => TimberService {#7068}
"translations" => array:36 [
"welcome" => "Yagami Starter Theme"
"filter_by_status" => "Screening by category"
"sector" => "Sector"
"type_of_operation" => "Status"
"filter_by_team" => "Screening by team"
"filter_by_location" => "Screening by location"
"invest_relation" => "Investor Relations"
"esg" => "ESG"
"compliance" => "Compliance"
"board" => "Board of Directors"
"executive_committee" => "Executive Committee"
"invest" => "Investment"
"admin_finance" => "Administration & Finance"
"back_to_news" => "back to news"
"back_to_team" => "Back to team"
"filter" => "Screening"
"discover" => "Discover"
"lbo_mid" => "LBO Mid Cap"
"lbo_small" => "LBO Small Cap"
"venture" => "Venture"
"real_estate" => "Real Estate"
"debt" => "Debt"
"send" => "Send"
"detention" => "Holding period"
"date_acquisition" => "Date d'acquisition"
"date_cession" => "Date de cession"
"country" => "pays"
"site" => "website"
"society" => "Company"
"press" => "Communiqué de presse"
"download" => "Télécharger le communiqué de presse"
"all_members" => "See entire team "
"all_news" => "All"
"show_more" => "Show more"
"all" => "All"
"cookiepro_params" => "Paramètres des cookies"
]
"img" => "https://www.lbofrance.com/wp-content/themes/yagami/web/src/img"
"dist" => "https://www.lbofrance.com/wp-content/themes/yagami/web/dist"
"options" => array:8 [
"footer_adveris_link" => "https://www.adveris.fr/"
"footer_adveris_title" => "Website creation : Adveris"
"footer_links" => array:2 [
0 => array:1 [
"link" => array:3 [
"title" => "Videos : Raccord Image"
"url" => "http://www.raccordimage.com/"
"target" => "_blank"
]
]
1 => array:1 [
"link" => array:3 [
"title" => "Photos : Encre Noire"
"url" => "http://www.encrenoire.com/en"
"target" => "_blank"
]
]
]
"footer_ml" => array:3 [
0 => array:2 [
"title" => "Copyright © 2020 LBO FRANCE"
"link" => ""
]
1 => array:2 [
"title" => "Legal notice"
"link" => "/en/disclaimer/"
]
2 => array:2 [
"title" => "Contact"
"link" => "https://www.lbofrance.com/en/contact/"
]
]
"link_externe" => array:3 [
"title" => "Un Autre Regard Créatif"
"url" => "https://www.un-autre-regard-creatif.com/"
"target" => "_blank"
]
"script_header" => """
<!-- CookiePro Cookies Consent Notice start for www.lbofrance.com -->\r\n
<script type="text/javascript" src="https://cookie-cdn.cookiepro.com/consent/0c5631b1-59d9-4b6d-91b8-d1cbc19ebae7/OtAutoBlock.js" ></script>\r\n
<script src="https://cookie-cdn.cookiepro.com/scripttemplates/otSDKStub.js" data-document-language="true" type="text/javascript" charset="UTF-8" data-domain-script="0c5631b1-59d9-4b6d-91b8-d1cbc19ebae7" ></script>\r\n
<script type="text/javascript">\r\n
function OptanonWrapper() { }\r\n
</script>\r\n
<!-- CookiePro Cookies Consent Notice end for www.lbofrance.com -->
"""
"social_linkedin" => "https://www.linkedin.com/company/lbo-france?originalSubdomain=it"
"team_link" => "https://www.lbofrance.com/en/team/"
]
"is_device" => false
"links" => array:2 [
"archives" => array:1 [
"news" => "https://www.lbofrance.com/en/news-and-press-release/"
]
"pages" => array:1 [
"page_exemple" => "https://www.lbofrance.com/en/lbo-france-announces-its-investment-in-tribvn-healthcare/"
]
]
"clear_head_for_yoast" => true
"google_map_api_key" => "AIzaSyDGF98psyVSiyiVhFovqfhMDrGJ-Ls2Uoc"
"server" => array:46 [
"SERVER_SOFTWARE" => "Apache/2.4.56 (Debian)"
"REQUEST_URI" => "/en/lbo-france-announces-its-investment-in-tribvn-healthcare/"
"DOCUMENT_ROOT" => "/var/www/lbofrance.com/docs"
"TMPDIR" => "/tmp"
"TMP" => "/tmp"
"TEMP" => "/tmp"
"PATH" => "/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin"
"HOSTNAME" => "a1c033e8c2ed"
"USER" => "phpuser"
"HOME" => "/var/www"
"SCRIPT_NAME" => "/index.php"
"QUERY_STRING" => ""
"REQUEST_METHOD" => "GET"
"SERVER_PROTOCOL" => "HTTP/1.1"
"GATEWAY_INTERFACE" => "CGI/1.1"
"REDIRECT_URL" => "/en/lbo-france-announces-its-investment-in-tribvn-healthcare/"
"REMOTE_PORT" => "50422"
"SCRIPT_FILENAME" => "/var/www/lbofrance.com/docs/index.php"
"SERVER_ADMIN" => "[no address given]"
"CONTEXT_DOCUMENT_ROOT" => "/var/www/lbofrance.com/docs"
"CONTEXT_PREFIX" => ""
"REQUEST_SCHEME" => "https"
"REMOTE_ADDR" => "34.229.131.158"
"SERVER_PORT" => "443"
"SERVER_ADDR" => "192.168.219.15"
"SERVER_NAME" => "www.lbofrance.com"
"SERVER_SIGNATURE" => "<address>Apache/2.4.56 (Debian) Server at www.lbofrance.com Port 443</address>\n"
"HTTP_CONNECTION" => "Keep-Alive"
"HTTP_HOST" => "www.lbofrance.com"
"HTTP_ACCEPT_ENCODING" => "br,gzip"
"HTTP_IF_MODIFIED_SINCE" => "Sat, 25 Jun 2022 11:53:00 GMT"
"HTTP_ACCEPT_LANGUAGE" => "en-US,en;q=0.5"
"HTTP_ACCEPT" => "text/html,application/xhtml+xml,application/xml;q=0.9,*/*;q=0.8"
"HTTP_USER_AGENT" => "CCBot/2.0 (https://commoncrawl.org/faq/)"
"proxy-nokeepalive" => "1"
"SSL_TLS_SNI" => "www.lbofrance.com"
"HTTPS" => "on"
"HTTP_AUTHORIZATION" => ""
"REDIRECT_STATUS" => "200"
"REDIRECT_SSL_TLS_SNI" => "www.lbofrance.com"
"REDIRECT_HTTPS" => "on"
"REDIRECT_HTTP_AUTHORIZATION" => ""
"FCGI_ROLE" => "RESPONDER"
"PHP_SELF" => "/index.php"
"REQUEST_TIME_FLOAT" => 1685602153.7314
"REQUEST_TIME" => 1685602153
]
"lang" => "en"
"current_language" => "en"
"http_host" => "https://www.lbofrance.com"
"wp_title" => "LBO France announces its investment in TRIBVN HEALTHCARE - LBO France"
"body_class" => "post-template-default single single-post postid-2132 single-format-standard"
"site" => Site {#7018
+admin_email: "admin@adveris.fr"
+blogname: null
+charset: "UTF-8"
+description: ""
+id: null
+language: "en_US"
+multisite: false
+name: "LBO France"
+pingback_url: "https://www.lbofrance.com/xmlrpc.php"
+siteurl: null
+theme: Theme {#7031
+name: "Yagami"
+version: ""
+parent: false
+parent_slug: null
+slug: "yagami"
+uri: "https://www.lbofrance.com/wp-content/themes/yagami"
-theme: WP_Theme {#7029
+update: false
-theme_root: "/var/www/lbofrance.com/docs/wp-content/themes"
-headers: array:14 [
"Name" => "Yagami"
"ThemeURI" => ""
"Description" => "Custom starter to build wordpress theme from scratch"
"Author" => "Kévin Vacherot"
"AuthorURI" => "https://www.linkedin.com/in/k%C3%A9vin-vacherot-b9a004a2/"
"Version" => ""
"Template" => ""
"Status" => ""
"Tags" => "yagami, blank"
"TextDomain" => "Yagami"
"DomainPath" => ""
"RequiresWP" => ""
"RequiresPHP" => ""
"UpdateURI" => ""
]
-headers_sanitized: array:2 [
"Name" => "Yagami"
"Version" => ""
]
-block_theme: false
-name_translated: null
-errors: null
-stylesheet: "yagami"
-template: "yagami"
-parent: null
-theme_root_uri: "https://www.lbofrance.com/wp-content/themes"
-textdomain_loaded: null
-cache_hash: "37a7699c69410d0bf18f875580b71453"
}
+id: null
+ID: null
+object_type: null
}
+title: "LBO France"
+url: "https://www.lbofrance.com/en/"
+home_url: "https://www.lbofrance.com/en/"
+site_url: "https://www.lbofrance.com"
+rdf: "https://www.lbofrance.com/en/feed/rdf/"
+rss: "https://www.lbofrance.com/en/feed/rss/"
+rss2: "https://www.lbofrance.com/en/feed/"
+atom: "https://www.lbofrance.com/en/feed/atom/"
+ID: null
+object_type: null
+"pingback": "https://www.lbofrance.com/xmlrpc.php"
}
"request" => Request {#7030
+post: []
+get: []
+id: null
+ID: null
+object_type: null
}
"user" => false
"theme" => Theme {#7031}
"posts" => PostQuery {#7033
+found_posts: 1
#userQuery: false
#queryIterator: QueryIterator {#7034
-_query: WP_Query {#4911
+query: array:2 [
"page" => ""
"name" => "lbo-france-announces-its-investment-in-tribvn-healthcare"
]
+query_vars: array:67 [
"page" => 0
"error" => ""
"m" => ""
"p" => 2132
"post_parent" => ""
"subpost" => ""
"subpost_id" => ""
"attachment" => ""
"attachment_id" => 0
"pagename" => ""
"page_id" => ""
"second" => ""
"minute" => ""
"hour" => ""
"day" => 0
"monthnum" => 0
"year" => 0
"w" => 0
"category_name" => ""
"tag" => ""
"cat" => ""
"tag_id" => ""
"author" => ""
"author_name" => ""
"feed" => ""
"tb" => ""
"paged" => 0
"meta_key" => ""
"meta_value" => ""
"preview" => ""
"s" => ""
"sentence" => ""
"title" => ""
"fields" => ""
"menu_order" => ""
"embed" => ""
"category__in" => []
"category__not_in" => []
"category__and" => []
"post__in" => []
"post__not_in" => []
"post_name__in" => []
"tag__in" => []
"tag__not_in" => []
"tag__and" => []
"tag_slug__in" => []
"tag_slug__and" => []
"post_parent__in" => []
"post_parent__not_in" => []
"author__in" => []
"author__not_in" => []
"search_columns" => []
"meta_query" => []
"name" => ""
"ignore_sticky_posts" => false
"suppress_filters" => false
"cache_results" => true
"update_post_term_cache" => true
"update_menu_item_cache" => false
"lazy_load_term_meta" => true
"update_post_meta_cache" => true
"post_type" => ""
"posts_per_page" => 9
"nopaging" => false
"comments_per_page" => "50"
"no_found_rows" => false
"order" => "DESC"
]
+tax_query: null
+meta_query: WP_Meta_Query {#7000
+queries: []
+relation: null
+meta_table: null
+meta_id_column: null
+primary_table: null
+primary_id_column: null
#table_aliases: []
#clauses: []
#has_or_relation: false
}
+date_query: false
+queried_object: WP_Post {#6992
+ID: 2132
+post_author: "1"
+post_date: "2019-07-16 13:42:56"
+post_date_gmt: "2019-07-16 11:42:56"
+post_content: """
<strong>TRIBVN Healthcare announces a €5m ($5.6m) fundraising campaign financed by LBO France through its Digital Health 2 venture fund. As a major player in digital pathology augmented by artificial intelligence, TRIBVN Healthcare develops a complete imaging software suite combining workstation, diagnostic assistance and telemedicine. </strong>\r\n
\r\n
This fundraising will enable TRIBVN Healthcare to become the leader in the digital transition of diagnostic and research laboratories in Europe and North America. TRIBVN Healthcare's innovation enables its customers to be more efficient and more secure in their practices. These are today the major challenges of diagnosis in the context of increasingly personalized and data driven medicine, particularly in oncology.\r\n
\r\n
In addition to accelerating international business development, the fundraising will enhance CaloPix and TeleSlide solutions by integrating the latest technological innovations from the Cloud and AI. With its experience and roots in the largest clinical and research institutions in Europe and Canada, TRIBVN Healthcare will continue to work and ensure that this digital transformation takes place with physicians and for the benefit of patients, thus creating real and lasting value.\r\n
\r\n
<strong>Jean-François Pomerol, CEO of TRIBVN Healthcare</strong>, explains:<em> "I am very excited that LBO France is supporting us in the next phase of TRIBVN Healthcare's development. The professionalism and experience of the venture health team is an undeniable recognition of our know-how and a strong commitment in our ability to transform cellular diagnostics at an international scale. The funding will allow us to increase the added value of our solutions and provide effective solutions to the problems faced by laboratories." </em>\r\n
\r\n
<strong>Sébastien Woynar, Investment Director</strong> at LBO France, adds: <em>“Artificial intelligence enhanced digital pathology is revolutionizing pathology and several medical specialties, such as oncology. TRIBVN Healthcare has a remarkable understanding of the field of pathology and a deep product portfolio, key success factors to build a global footprint. This support strengthens TRIBVN Healthcare's ability to be, on a global scale, the privileged partner of pathology laboratories and research centers.” </em>\r\n
\r\n
<strong>About TRIBVN Healthcare:</strong>\r\n
\r\n
TRIBVN Healthcare develops software solutions for digital pathology. Innovative and validated, they allow the management, analysis and sharing of cellular images both for diagnostic laboratories and pharmaceutical & biotech manufacturers.\r\n
\r\n
In the field of image analysis, our solutions are based on the latest innovations in terms of artificial intelligence, notably deep and machine learning algorithms. These tools support physicians and researchers in their diagnostic decision-making and scientific evaluation for the sake of patients.\r\n
\r\n
In the field of sharing, our solutions implement full web tools to support our customers in their telepathology, teaching or multi-centric clinical validation activities.\r\n
\r\n
Find out more: <a href="http://www.tribvn-hc.com">www.tribvn-hc.com</a> - <a href="http://www.teleslide.com">www.teleslide.com </a>\r\n
\r\n
Contact: Jean-François Pomerol - CEO - jfpomerol@tribvn-hc.com\r\n
\r\n
Media Contact: Pauline Baldo, Marketing & Communication manager – pbaldo@tribvn-hc.com - +33 1 55 58 05 35\r\n
\r\n
<strong> About LBO France: </strong>\r\n
\r\n
As a key player in private equity with €4bn of capital under management, LBO France is an independent company that has been supporting European companies in their growth for more than 30 years. Its investment strategy is built on 4 distinct segments managed by dedicated teams: (i) Mid Cap Buyout through the White Knight funds and Small Cap Buyout through the Hexagone/Small Caps Opportunities funds, (ii) Venture Capital through the SISA/Digital Health funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100% owned by its management and employs nearly 60 professionals.\r\n
\r\n
Find out more: <a href="http://www.lbofrance.com">www.lbofrance.com </a>\r\n
\r\n
Contact: Sébastien Woynar, Investment Director - sebastien.woynar@lbofrance.com\r\n
\r\n
<strong>Media Contact: </strong>\r\n
\r\n
Agence Shan\r\n
\r\n
Léa Schultz - + 33 1 42 86 82 41 – lea.schultz@shan.fr\r\n
\r\n
Laetitia Hottinguer - + 33 1 44 50 58 78 – laetitia.hottinguer@shan.fr\r\n
\r\n
\r\n
\r\n
\r\n
\r\n
<a href="https://www.lbofrance.com/wp-content/uploads/2019/12/cp-ldf-thc-final-en.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
"""
+post_title: "LBO France announces its investment in TRIBVN HEALTHCARE"
+post_excerpt: ""
+post_status: "publish"
+comment_status: "open"
+ping_status: "closed"
+post_password: ""
+post_name: "lbo-france-announces-its-investment-in-tribvn-healthcare"
+to_ping: ""
+pinged: ""
+post_modified: "2020-02-11 14:43:29"
+post_modified_gmt: "2020-02-11 13:43:29"
+post_content_filtered: ""
+post_parent: 0
+guid: "https://www.lbofrance.com/lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare/"
+menu_order: 0
+post_type: "post"
+post_mime_type: ""
+comment_count: "0"
+filter: "raw"
+"status": "publish"
+"id": 2132
+"slug": "lbo-france-announces-its-investment-in-tribvn-healthcare"
+"custom": array:16 [
"_wpml_media_featured" => "1"
"_wpml_media_duplicate" => "1"
"_yoast_wpseo_content_score" => "30"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => ""
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => ""
"_wp_old_date" => array:2 [
0 => "2019-12-18"
1 => "2019-07-19"
]
"_edit_lock" => "1581428469:1"
"_edit_last" => "1"
"_wp_old_slug" => "lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare"
"_last_translation_edit_mode" => "native-editor"
"_wpml_media_has_media" => "1"
]
}
+queried_object_id: 2132
+request: """
\n
\t\t\tSELECT lbo_posts.*\n
\t\t\tFROM lbo_posts JOIN lbo_icl_translations wpml_translations\n
\t\t\t\t\t\t\tON lbo_posts.ID = wpml_translations.element_id\n
\t\t\t\t\t\t\t\tAND wpml_translations.element_type = CONCAT('post_', lbo_posts.post_type) \n
\t\t\tWHERE 1=1 AND lbo_posts.ID = 2132 AND lbo_posts.post_type = 'post' AND ( ( ( wpml_translations.language_code = 'en' OR 0 ) AND lbo_posts.post_type IN ('post','page','attachment','wp_block','wp_template','wp_template_part','wp_navigation','members','investments' ) ) OR lbo_posts.post_type NOT IN ('post','page','attachment','wp_block','wp_template','wp_template_part','wp_navigation','members','investments' ) )\n
\t\t\t\n
\t\t\tORDER BY lbo_posts.post_date DESC\n
\t\t\t\n
\t\t
"""
+posts: & array:1 [
0 => WP_Post {#6992}
]
+post_count: 1
+current_post: -1
+in_the_loop: false
+post: WP_Post {#6992}
+comment_count: 0
+current_comment: -1
+found_posts: 1
+max_num_pages: 0
+max_num_comment_pages: 0
+is_single: true
+is_preview: false
+is_page: false
+is_archive: false
+is_date: false
+is_year: false
+is_month: false
+is_day: false
+is_time: false
+is_author: false
+is_category: false
+is_tag: false
+is_tax: false
+is_search: false
+is_feed: false
+is_comment_feed: false
+is_trackback: false
+is_home: false
+is_privacy_policy: false
+is_404: false
+is_embed: false
+is_paged: false
+is_admin: false
+is_attachment: false
+is_singular: true
+is_robots: false
+is_favicon: false
+is_posts_page: false
+is_post_type_archive: false
-query_vars_hash: "1421ed999af5d57e143dc76076e0290f"
-query_vars_changed: true
+thumbnails_cached: false
#allow_query_attachment_by_filename: false
-stopwords: null
-compat_fields: array:2 [
0 => "query_vars_hash"
1 => "query_vars_changed"
]
-compat_methods: array:2 [
0 => "init_query_flags"
1 => "parse_tax_query"
]
}
-_posts_class: "\Timber\Post"
}
#pagination: null
flag::STD_PROP_LIST: false
flag::ARRAY_AS_PROPS: false
iteratorClass: "Timber\PostsIterator"
storage: array:1 [
0 => Post {#7036
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:16 [
"_wpml_media_featured" => "1"
"_wpml_media_duplicate" => "1"
"_yoast_wpseo_content_score" => "30"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => ""
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => ""
"_wp_old_date" => array:2 [
0 => "2019-12-18"
1 => "2019-07-19"
]
"_edit_lock" => "1581428469:1"
"_edit_last" => "1"
"_wp_old_slug" => "lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare"
"_last_translation_edit_mode" => "native-editor"
"_wpml_media_has_media" => "1"
]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2132
+ID: 2132
+post_author: "1"
+post_content: """
<strong>TRIBVN Healthcare announces a €5m ($5.6m) fundraising campaign financed by LBO France through its Digital Health 2 venture fund. As a major player in digital pathology augmented by artificial intelligence, TRIBVN Healthcare develops a complete imaging software suite combining workstation, diagnostic assistance and telemedicine. </strong>\r\n
\r\n
This fundraising will enable TRIBVN Healthcare to become the leader in the digital transition of diagnostic and research laboratories in Europe and North America. TRIBVN Healthcare's innovation enables its customers to be more efficient and more secure in their practices. These are today the major challenges of diagnosis in the context of increasingly personalized and data driven medicine, particularly in oncology.\r\n
\r\n
In addition to accelerating international business development, the fundraising will enhance CaloPix and TeleSlide solutions by integrating the latest technological innovations from the Cloud and AI. With its experience and roots in the largest clinical and research institutions in Europe and Canada, TRIBVN Healthcare will continue to work and ensure that this digital transformation takes place with physicians and for the benefit of patients, thus creating real and lasting value.\r\n
\r\n
<strong>Jean-François Pomerol, CEO of TRIBVN Healthcare</strong>, explains:<em> "I am very excited that LBO France is supporting us in the next phase of TRIBVN Healthcare's development. The professionalism and experience of the venture health team is an undeniable recognition of our know-how and a strong commitment in our ability to transform cellular diagnostics at an international scale. The funding will allow us to increase the added value of our solutions and provide effective solutions to the problems faced by laboratories." </em>\r\n
\r\n
<strong>Sébastien Woynar, Investment Director</strong> at LBO France, adds: <em>“Artificial intelligence enhanced digital pathology is revolutionizing pathology and several medical specialties, such as oncology. TRIBVN Healthcare has a remarkable understanding of the field of pathology and a deep product portfolio, key success factors to build a global footprint. This support strengthens TRIBVN Healthcare's ability to be, on a global scale, the privileged partner of pathology laboratories and research centers.” </em>\r\n
\r\n
<strong>About TRIBVN Healthcare:</strong>\r\n
\r\n
TRIBVN Healthcare develops software solutions for digital pathology. Innovative and validated, they allow the management, analysis and sharing of cellular images both for diagnostic laboratories and pharmaceutical & biotech manufacturers.\r\n
\r\n
In the field of image analysis, our solutions are based on the latest innovations in terms of artificial intelligence, notably deep and machine learning algorithms. These tools support physicians and researchers in their diagnostic decision-making and scientific evaluation for the sake of patients.\r\n
\r\n
In the field of sharing, our solutions implement full web tools to support our customers in their telepathology, teaching or multi-centric clinical validation activities.\r\n
\r\n
Find out more: <a href="http://www.tribvn-hc.com">www.tribvn-hc.com</a> - <a href="http://www.teleslide.com">www.teleslide.com </a>\r\n
\r\n
Contact: Jean-François Pomerol - CEO - jfpomerol@tribvn-hc.com\r\n
\r\n
Media Contact: Pauline Baldo, Marketing & Communication manager – pbaldo@tribvn-hc.com - +33 1 55 58 05 35\r\n
\r\n
<strong> About LBO France: </strong>\r\n
\r\n
As a key player in private equity with €4bn of capital under management, LBO France is an independent company that has been supporting European companies in their growth for more than 30 years. Its investment strategy is built on 4 distinct segments managed by dedicated teams: (i) Mid Cap Buyout through the White Knight funds and Small Cap Buyout through the Hexagone/Small Caps Opportunities funds, (ii) Venture Capital through the SISA/Digital Health funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100% owned by its management and employs nearly 60 professionals.\r\n
\r\n
Find out more: <a href="http://www.lbofrance.com">www.lbofrance.com </a>\r\n
\r\n
Contact: Sébastien Woynar, Investment Director - sebastien.woynar@lbofrance.com\r\n
\r\n
<strong>Media Contact: </strong>\r\n
\r\n
Agence Shan\r\n
\r\n
Léa Schultz - + 33 1 42 86 82 41 – lea.schultz@shan.fr\r\n
\r\n
Laetitia Hottinguer - + 33 1 44 50 58 78 – laetitia.hottinguer@shan.fr\r\n
\r\n
\r\n
\r\n
\r\n
\r\n
<a href="https://www.lbofrance.com/wp-content/uploads/2019/12/cp-ldf-thc-final-en.pdf" target="_blank" rel="noopener noreferrer">Read Press Release</a>
"""
+post_date: "2019-07-16 13:42:56"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "LBO France announces its investment in TRIBVN HEALTHCARE"
+post_type: "post"
+slug: "lbo-france-announces-its-investment-in-tribvn-healthcare"
#__type: null
+"_wpml_media_featured": "1"
+"_wpml_media_duplicate": "1"
+"_yoast_wpseo_content_score": "30"
+"banner": ""
+"_banner": "field_5d0b8f67a8a14"
+"linkedin": ""
+"_linkedin": "field_5d0b8fa0a8a15"
+"fichier": ""
+"_fichier": "field_5d0b8faba8a16"
+"_yoast_wpseo_primary_category": ""
+"_wp_old_date": array:2 [
0 => "2019-12-18"
1 => "2019-07-19"
]
+"_edit_lock": "1581428469:1"
+"_edit_last": "1"
+"_wp_old_slug": "lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare"
+"_last_translation_edit_mode": "native-editor"
+"_wpml_media_has_media": "1"
+"post_date_gmt": "2019-07-16 11:42:56"
+"comment_status": "open"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "lbo-france-announces-its-investment-in-tribvn-healthcare"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2020-02-11 14:43:29"
+"post_modified_gmt": "2020-02-11 13:43:29"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare/"
+"menu_order": 0
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"status": "publish"
}
]
}
"wp_head" => FunctionWrapper {#7035
-_class: null
-_function: "wp_head"
-_args: []
-_use_ob: false
}
"wp_footer" => FunctionWrapper {#7041
-_class: null
-_function: "wp_footer"
-_args: []
-_use_ob: false
}
"menu" => array:3 [
"primary" => Menu {#7043
+MenuItemClass: "Timber\MenuItem"
+PostClass: "Timber\Post"
+depth: 0
+items: array:4 [
0 => MenuItem {#2368
+children: array:5 [
0 => MenuItem {#7747
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-5083"
+level: 1
+post_name: "presentation"
+url: "https://www.lbofrance.com/en/about-lbo-france#section-0"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "5083"
#_menu_item_url: "https://www.lbofrance.com/en/about-lbo-france#section-0"
#menu_object: Post {#7742 …62}
+id: 5083
+ID: 5083
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:9 [ …9]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Presentation"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "2485"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2021-03-23 11:33:44"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5083"
+"menu_order": 2
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 5083
+"menu_item_parent": "2485"
+"object_id": "5083"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Presentation"
+"status": "publish"
+"name": "Presentation"
}
1 => MenuItem {#7739
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-5085"
+level: 1
+post_name: "board-of-directors"
+url: "https://www.lbofrance.com/en/about-lbo-france#section-1"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "5085"
#_menu_item_url: "https://www.lbofrance.com/en/about-lbo-france#section-1"
#menu_object: Post {#7752 …62}
+id: 5085
+ID: 5085
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:9 [ …9]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Board of Directors"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "2485"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2021-03-23 11:33:44"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5085"
+"menu_order": 3
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 5085
+"menu_item_parent": "2485"
+"object_id": "5085"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Board of Directors"
+"status": "publish"
+"name": "Board of Directors"
}
2 => MenuItem {#7745
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-5087"
+level: 1
+post_name: "operational-value-creation"
+url: "https://www.lbofrance.com/en/about-lbo-france#section-2"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "5087"
#_menu_item_url: "https://www.lbofrance.com/en/about-lbo-france#section-2"
#menu_object: Post {#7743 …62}
+id: 5087
+ID: 5087
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:9 [ …9]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Operational Value Creation"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "2485"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2021-03-23 11:33:44"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5087"
+"menu_order": 4
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 5087
+"menu_item_parent": "2485"
+"object_id": "5087"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Operational Value Creation"
+"status": "publish"
+"name": "Operational Value Creation"
}
3 => MenuItem {#7734
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-5088"
+level: 1
+post_name: "esg"
+url: "https://www.lbofrance.com/en/about-lbo-france#section-3"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "5088"
#_menu_item_url: "https://www.lbofrance.com/en/about-lbo-france#section-3"
#menu_object: Post {#7741 …62}
+id: 5088
+ID: 5088
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:9 [ …9]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "ESG"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "2485"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2021-03-23 11:33:44"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5088"
+"menu_order": 5
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 5088
+"menu_item_parent": "2485"
+"object_id": "5088"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "ESG"
+"status": "publish"
+"name": "ESG"
}
4 => MenuItem {#7736
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-5090"
+level: 1
+post_name: "investor-relations"
+url: "https://www.lbofrance.com/en/about-lbo-france#section-4"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "5090"
#_menu_item_url: "https://www.lbofrance.com/en/about-lbo-france#section-4"
#menu_object: Post {#7737 …62}
+id: 5090
+ID: 5090
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:9 [ …9]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Investor Relations"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "2485"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2021-03-23 11:33:44"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5090"
+"menu_order": 6
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 5090
+"menu_item_parent": "2485"
+"object_id": "5090"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Investor Relations"
+"status": "publish"
+"name": "Investor Relations"
}
]
+has_child_class: true
+classes: array:6 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-post_type"
3 => "menu-item-object-page"
4 => "menu-item-2485"
5 => "menu-item-has-children"
]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-2485 menu-item-has-children"
+level: 0
+post_name: "2485"
+url: "https://www.lbofrance.com/en/about-lbo-france/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "1555"
#_menu_item_url: ""
#menu_object: Post {#983
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [
"_menu_item_type" => "post_type"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "1555"
"_menu_item_object" => "page"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => ""
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:4 [ …4]
]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2485
+ID: 2485
+post_author: "1"
+post_content: " "
+post_date: "2023-03-21 18:25:18"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: ""
+post_type: "nav_menu_item"
+slug: "2485"
#__type: null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "1555"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_menu_item_url": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [
0 => "2019-12-27"
1 => "2021-05-21"
2 => "2022-09-09"
3 => "2022-09-12"
]
+"post_date_gmt": "2019-12-27 10:52:08"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "2485"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2485/"
+"menu_order": 1
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2485
+"menu_item_parent": "0"
+"object_id": "1555"
+"object": "page"
+"type_label": "Page"
+"url": "https://www.lbofrance.com/en/about-lbo-france/"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:4 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-post_type"
3 => "menu-item-object-page"
]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "Company"
+"status": "publish"
}
+id: 2485
+ID: 2485
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "post_type"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "1555"
"_menu_item_object" => "page"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [
0 => ""
]
"_menu_item_xfn" => ""
"_menu_item_url" => ""
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:4 [
0 => "2019-12-27"
1 => "2021-05-21"
2 => "2022-09-09"
3 => "2022-09-12"
]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [
0 => "2019-12-27"
1 => "2021-05-21"
2 => "2022-09-09"
3 => "2022-09-12"
]
+"post_date_gmt": "2019-12-27 10:52:08"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2485/"
+"menu_order": 1
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2485
+"menu_item_parent": "0"
+"object_id": "1555"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Company"
+"status": "publish"
+"name": "Company"
}
1 => MenuItem {#7732
+children: array:5 [
0 => MenuItem {#7730
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-2487"
+level: 1
+post_name: "2487"
+url: "https://www.lbofrance.com/en/lbo-mid-cap/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "1536"
#_menu_item_url: ""
#menu_object: Post {#7733 …63}
+id: 2487
+ID: 2487
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [ …10]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "2486"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:11"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2487/"
+"menu_order": 8
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2487
+"menu_item_parent": "2486"
+"object_id": "1536"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "LBO Mid Cap"
+"status": "publish"
+"name": "LBO Mid Cap"
}
1 => MenuItem {#7728
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-2488"
+level: 1
+post_name: "2488"
+url: "https://www.lbofrance.com/en/lbo-small-cap/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "1529"
#_menu_item_url: ""
#menu_object: Post {#7729 …63}
+id: 2488
+ID: 2488
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [ …10]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "2486"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:12"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2488/"
+"menu_order": 9
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2488
+"menu_item_parent": "2486"
+"object_id": "1529"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "LBO Small Cap"
+"status": "publish"
+"name": "LBO Small Cap"
}
2 => MenuItem {#7726
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-2489"
+level: 1
+post_name: "2489"
+url: "https://www.lbofrance.com/en/real-estate/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "1531"
#_menu_item_url: ""
#menu_object: Post {#7727 …63}
+id: 2489
+ID: 2489
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [ …10]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "2486"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:13"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2489/"
+"menu_order": 10
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2489
+"menu_item_parent": "2486"
+"object_id": "1531"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Real Estate Proptech"
+"status": "publish"
+"name": "Real Estate Proptech"
}
3 => MenuItem {#7724
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-2490"
+level: 1
+post_name: "2490"
+url: "https://www.lbofrance.com/en/venture/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "1533"
#_menu_item_url: ""
#menu_object: Post {#7725 …63}
+id: 2490
+ID: 2490
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [ …10]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "2486"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:14"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2490/"
+"menu_order": 11
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2490
+"menu_item_parent": "2486"
+"object_id": "1533"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Venture Digital Health"
+"status": "publish"
+"name": "Venture Digital Health"
}
4 => MenuItem {#7722
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-5374"
+level: 1
+post_name: "5374"
+url: "https://www.lbofrance.com/en/public-equity/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "5357"
#_menu_item_url: ""
#menu_object: Post {#7723 …63}
+id: 5374
+ID: 5374
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [ …10]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "2486"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_wp_old_date": array:3 [ …3]
+"_last_translation_edit_mode": "translation-editor"
+"post_date_gmt": "2021-05-21 09:53:35"
…25
}
]
+has_child_class: true
+classes: array:6 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-custom"
3 => "menu-item-object-custom"
4 => "menu-item-2486"
5 => "menu-item-has-children"
]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-2486 menu-item-has-children"
+level: 0
+post_name: "activites"
+url: "#"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "2486"
#_menu_item_url: "#"
#menu_object: Post {#7731
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [ …10]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2486
+ID: 2486
+post_author: "1"
+post_content: ""
+post_date: "2023-03-21 18:25:18"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "Expertises"
+post_type: "nav_menu_item"
+slug: "activites"
#__type: null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "2486"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_menu_item_url": "#"
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:09"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "activites"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/activites/"
+"menu_order": 7
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2486
+"menu_item_parent": "0"
+"object_id": "2486"
+"object": "custom"
+"type_label": "Custom Link"
+"url": "#"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:4 [ …4]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "Expertises"
+"status": "publish"
}
+id: 2486
+ID: 2486
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "custom"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "2486"
"_menu_item_object" => "custom"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => "#"
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:4 [ …4]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Expertises"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [
0 => "2019-12-27"
1 => "2021-05-21"
2 => "2022-09-09"
3 => "2022-09-12"
]
+"post_date_gmt": "2019-12-27 10:52:09"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/activites/"
+"menu_order": 7
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2486
+"menu_item_parent": "0"
+"object_id": "2486"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Expertises"
+"status": "publish"
+"name": "Expertises"
}
2 => MenuItem {#7720
+children: []
+has_child_class: false
+classes: array:5 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-custom"
3 => "menu-item-object-custom"
4 => "menu-item-2492"
]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-2492"
+level: 0
+post_name: "portefeuille-2"
+url: "https://www.lbofrance.com/en/portfolio/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "2492"
#_menu_item_url: "https://www.lbofrance.com/en/portfolio/"
#menu_object: Post {#7721
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [ …10]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2492
+ID: 2492
+post_author: "1"
+post_content: ""
+post_date: "2023-03-21 18:25:18"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "Portfolio"
+post_type: "nav_menu_item"
+slug: "portefeuille-2"
#__type: null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "2492"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_menu_item_url": "https://www.lbofrance.com/en/portfolio/"
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:17"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "portefeuille-2"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/portefeuille-2/"
+"menu_order": 13
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2492
+"menu_item_parent": "0"
+"object_id": "2492"
+"object": "custom"
+"type_label": "Custom Link"
+"url": "https://www.lbofrance.com/en/portfolio/"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:4 [ …4]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "Portfolio"
+"status": "publish"
}
+id: 2492
+ID: 2492
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "custom"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "2492"
"_menu_item_object" => "custom"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => "https://www.lbofrance.com/en/portfolio/"
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:4 [ …4]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Portfolio"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [
0 => "2019-12-27"
1 => "2021-05-21"
2 => "2022-09-09"
3 => "2022-09-12"
]
+"post_date_gmt": "2019-12-27 10:52:17"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/portefeuille-2/"
+"menu_order": 13
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2492
+"menu_item_parent": "0"
+"object_id": "2492"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Portfolio"
+"status": "publish"
+"name": "Portfolio"
}
3 => MenuItem {#7718
+children: []
+has_child_class: false
+classes: array:5 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-custom"
3 => "menu-item-object-custom"
4 => "menu-item-2493"
]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-2493"
+level: 0
+post_name: "equipe-2"
+url: "https://www.lbofrance.com/en/team/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7043}
#_name: null
#_menu_item_object_id: "2493"
#_menu_item_url: "https://www.lbofrance.com/en/team/"
#menu_object: Post {#7719
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [ …10]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2493
+ID: 2493
+post_author: "1"
+post_content: ""
+post_date: "2023-03-21 18:25:18"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "Team"
+post_type: "nav_menu_item"
+slug: "equipe-2"
#__type: null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "2493"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_menu_item_url": "https://www.lbofrance.com/en/team/"
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:18"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "equipe-2"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/equipe-2/"
+"menu_order": 14
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2493
+"menu_item_parent": "0"
+"object_id": "2493"
+"object": "custom"
+"type_label": "Custom Link"
+"url": "https://www.lbofrance.com/en/team/"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:4 [ …4]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "Team"
+"status": "publish"
}
+id: 2493
+ID: 2493
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "custom"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "2493"
"_menu_item_object" => "custom"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => "https://www.lbofrance.com/en/team/"
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:4 [ …4]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Team"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [
0 => "2019-12-27"
1 => "2021-05-21"
2 => "2022-09-09"
3 => "2022-09-12"
]
+"post_date_gmt": "2019-12-27 10:52:18"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/equipe-2/"
+"menu_order": 14
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2493
+"menu_item_parent": "0"
+"object_id": "2493"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Team"
+"status": "publish"
+"name": "Team"
}
]
+id: 73
+ID: 73
+term_id: 73
+name: "Main menu - en"
+title: "Main menu - en"
+options: array:1 [
"depth" => 0
]
+raw_options: []
+theme_location: null
+TermClass: "Term"
+object_type: "term"
+_children: null
+taxonomy: "nav_menu"
+"slug": "main-menu-en"
+"term_group": 0
+"term_taxonomy_id": 73
+"parent": 0
+"count": 14
+"filter": "raw"
+"term_order": "0"
}
"secondary" => Menu {#7080
+MenuItemClass: "Timber\MenuItem"
+PostClass: "Timber\Post"
+depth: 0
+items: array:5 [
0 => MenuItem {#7216
+children: []
+has_child_class: false
+classes: array:6 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-post_type"
3 => "menu-item-object-page"
4 => "current_page_parent"
5 => "menu-item-2494"
]
+class: "menu-item menu-item-type-post_type menu-item-object-page current_page_parent menu-item-2494"
+level: 0
+post_name: "2494"
+url: "https://www.lbofrance.com/en/news-and-press-release/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7080}
#_name: null
#_menu_item_object_id: "2124"
#_menu_item_url: ""
#menu_object: Post {#7217
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [ …10]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2494
+ID: 2494
+post_author: "1"
+post_content: ""
+post_date: "2021-10-14 18:39:04"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "News"
+post_type: "nav_menu_item"
+slug: "2494"
#__type: null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "2124"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_menu_item_url": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:2 [ …2]
+"post_date_gmt": "2019-12-27 10:52:18"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "2494"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-10-14 18:39:04"
+"post_modified_gmt": "2021-10-14 16:39:04"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2494/"
+"menu_order": 1
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2494
+"menu_item_parent": "0"
+"object_id": "2124"
+"object": "page"
+"type_label": "Page"
+"url": "https://www.lbofrance.com/en/news-and-press-release/"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:5 [ …5]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "News"
+"status": "publish"
}
+id: 2494
+ID: 2494
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "post_type"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "2124"
"_menu_item_object" => "page"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => ""
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:2 [ …2]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2021-10-14 18:39:04"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "News"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:2 [
0 => "2019-12-27"
1 => "2021-10-13"
]
+"post_date_gmt": "2019-12-27 10:52:18"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-10-14 18:39:04"
+"post_modified_gmt": "2021-10-14 16:39:04"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2494/"
+"menu_order": 1
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2494
+"menu_item_parent": "0"
+"object_id": "2124"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "News"
+"status": "publish"
+"name": "News"
}
1 => MenuItem {#7218
+children: array:2 [
0 => MenuItem {#7136 …69}
1 => MenuItem {#7139 …69}
]
+has_child_class: true
+classes: array:6 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-custom"
3 => "menu-item-object-custom"
4 => "menu-item-2495"
5 => "menu-item-has-children"
]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-2495 menu-item-has-children"
+level: 0
+post_name: "investisseurs-2"
+url: "#"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7080}
#_name: null
#_menu_item_object_id: "2495"
#_menu_item_url: "#"
#menu_object: Post {#7219
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [ …10]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2495
+ID: 2495
+post_author: "1"
+post_content: ""
+post_date: "2021-10-14 18:39:04"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "Investors"
+post_type: "nav_menu_item"
+slug: "investisseurs-2"
#__type: null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "2495"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_menu_item_url": "#"
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:2 [ …2]
+"post_date_gmt": "2019-12-27 10:52:19"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "investisseurs-2"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-10-14 18:39:04"
+"post_modified_gmt": "2021-10-14 16:39:04"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/investisseurs-2/"
+"menu_order": 2
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2495
+"menu_item_parent": "0"
+"object_id": "2495"
+"object": "custom"
+"type_label": "Custom Link"
+"url": "#"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:4 [ …4]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "Investors"
+"status": "publish"
}
+id: 2495
+ID: 2495
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "custom"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "2495"
"_menu_item_object" => "custom"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => "#"
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:2 [ …2]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2021-10-14 18:39:04"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Investors"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:2 [
0 => "2019-12-27"
1 => "2021-10-13"
]
+"post_date_gmt": "2019-12-27 10:52:19"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-10-14 18:39:04"
+"post_modified_gmt": "2021-10-14 16:39:04"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/investisseurs-2/"
+"menu_order": 2
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2495
+"menu_item_parent": "0"
+"object_id": "2495"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Investors"
+"status": "publish"
+"name": "Investors"
}
2 => MenuItem {#7140
+children: []
+has_child_class: false
+classes: array:5 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-post_type"
3 => "menu-item-object-page"
4 => "menu-item-2498"
]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-2498"
+level: 0
+post_name: "2498"
+url: "https://www.lbofrance.com/en/contact-us/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7080}
#_name: null
#_menu_item_object_id: "2123"
#_menu_item_url: ""
#menu_object: Post {#7141
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [ …10]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2498
+ID: 2498
+post_author: "1"
+post_content: " "
+post_date: "2021-10-14 18:39:05"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: ""
+post_type: "nav_menu_item"
+slug: "2498"
#__type: null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "2123"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_menu_item_url": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:2 [ …2]
+"post_date_gmt": "2019-12-27 10:52:22"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "2498"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-10-14 18:39:05"
+"post_modified_gmt": "2021-10-14 16:39:05"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2498/"
+"menu_order": 5
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2498
+"menu_item_parent": "0"
+"object_id": "2123"
+"object": "page"
+"type_label": "Page"
+"url": "https://www.lbofrance.com/en/contact-us/"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:4 [ …4]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "Contact us"
+"status": "publish"
}
+id: 2498
+ID: 2498
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "post_type"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "2123"
"_menu_item_object" => "page"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => ""
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:2 [ …2]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2021-10-14 18:39:05"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:2 [
0 => "2019-12-27"
1 => "2021-10-13"
]
+"post_date_gmt": "2019-12-27 10:52:22"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-10-14 18:39:05"
+"post_modified_gmt": "2021-10-14 16:39:05"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2498/"
+"menu_order": 5
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2498
+"menu_item_parent": "0"
+"object_id": "2123"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Contact us"
+"status": "publish"
+"name": "Contact us"
}
3 => MenuItem {#7143
+children: []
+has_child_class: false
+classes: array:9 [
0 => "menu-item"
1 => "wpml-ls-slot-5"
2 => "wpml-ls-item"
3 => "wpml-ls-item-fr"
4 => "wpml-ls-menu-item"
5 => "wpml-ls-first-item"
6 => "menu-item-type-wpml_ls_menu_item"
7 => "menu-item-object-wpml_ls_menu_item"
8 => "menu-item-wpml-ls-5-fr"
]
+class: "menu-item wpml-ls-slot-5 wpml-ls-item wpml-ls-item-fr wpml-ls-menu-item wpml-ls-first-item menu-item-type-wpml_ls_menu_item menu-item-object-wpml_ls_menu_item menu-item-wpml-ls-5-fr"
+level: 0
+post_name: null
+url: "https://www.lbofrance.com/lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7080}
#_name: null
#_menu_item_object_id: null
#_menu_item_url: null
#menu_object: WPML_LS_Menu_Item {#7573
+ID: "wpml-ls-5-fr"
+attr_title: ""
+classes: array:8 [ …8]
+db_id: "wpml-ls-5-fr"
+description: null
+menu_item_parent: 0
+object: "wpml_ls_menu_item"
+object_id: "wpml-ls-5-fr"
+post_parent: null
+post_title: """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/fr.png"\n
alt="fr"\n
\n
\n
/>
"""
+target: null
+type: "wpml_ls_menu_item"
+type_label: null
+url: "https://www.lbofrance.com/lbo-france-annonce-un-investissement-dans-la-societe-tribvn-healthcare/"
+xfn: null
+_invalid: false
+menu_order: 6
+post_type: "nav_menu_item"
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/fr.png"\n
alt="fr"\n
\n
\n
/>
"""
}
+id: null
+ID: "wpml-ls-5-fr"
+object_type: null
+"attr_title": ""
+"db_id": "wpml-ls-5-fr"
+"description": null
+"menu_item_parent": 0
+"object": "wpml_ls_menu_item"
+"object_id": "wpml-ls-5-fr"
+"post_parent": null
+"post_title": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/fr.png"\n
alt="fr"\n
\n
\n
/>
"""
+"target": null
+"type_label": null
+"xfn": null
+"_invalid": false
+"menu_order": 6
+"post_type": "nav_menu_item"
+"__title": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/fr.png"\n
alt="fr"\n
\n
\n
/>
"""
+"name": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/fr.png"\n
alt="fr"\n
\n
\n
/>
"""
}
4 => MenuItem {#7110
+children: []
+has_child_class: false
+classes: array:10 [
0 => "menu-item"
1 => "wpml-ls-slot-5"
2 => "wpml-ls-item"
3 => "wpml-ls-item-en"
4 => "wpml-ls-current-language"
5 => "wpml-ls-menu-item"
6 => "wpml-ls-last-item"
7 => "menu-item-type-wpml_ls_menu_item"
8 => "menu-item-object-wpml_ls_menu_item"
9 => "menu-item-wpml-ls-5-en"
]
+class: "menu-item wpml-ls-slot-5 wpml-ls-item wpml-ls-item-en wpml-ls-current-language wpml-ls-menu-item wpml-ls-last-item menu-item-type-wpml_ls_menu_item menu-item-object-wpml_ls_menu_item menu-item-wpml-ls-5-en"
+level: 0
+post_name: null
+url: "https://www.lbofrance.com/en/lbo-france-announces-its-investment-in-tribvn-healthcare/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7080}
#_name: null
#_menu_item_object_id: null
#_menu_item_url: null
#menu_object: WPML_LS_Menu_Item {#7215
+ID: "wpml-ls-5-en"
+attr_title: ""
+classes: array:9 [ …9]
+db_id: "wpml-ls-5-en"
+description: null
+menu_item_parent: 0
+object: "wpml_ls_menu_item"
+object_id: "wpml-ls-5-en"
+post_parent: null
+post_title: """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en.png"\n
alt="en"\n
\n
\n
/>
"""
+target: null
+type: "wpml_ls_menu_item"
+type_label: null
+url: "https://www.lbofrance.com/en/lbo-france-announces-its-investment-in-tribvn-healthcare/"
+xfn: null
+_invalid: false
+menu_order: 7
+post_type: "nav_menu_item"
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en.png"\n
alt="en"\n
\n
\n
/>
"""
}
+id: null
+ID: "wpml-ls-5-en"
+object_type: null
+"attr_title": ""
+"db_id": "wpml-ls-5-en"
+"description": null
+"menu_item_parent": 0
+"object": "wpml_ls_menu_item"
+"object_id": "wpml-ls-5-en"
+"post_parent": null
+"post_title": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en.png"\n
alt="en"\n
\n
\n
/>
"""
+"target": null
+"type_label": null
+"xfn": null
+"_invalid": false
+"menu_order": 7
+"post_type": "nav_menu_item"
+"__title": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en.png"\n
alt="en"\n
\n
\n
/>
"""
+"name": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en.png"\n
alt="en"\n
\n
\n
/>
"""
}
]
+id: 74
+ID: 74
+term_id: 74
+name: "Menu secondaire - en"
+title: "Menu secondaire - en"
+options: array:1 [
"depth" => 0
]
+raw_options: []
+theme_location: null
+TermClass: "Term"
+object_type: "term"
+_children: null
+taxonomy: "nav_menu"
+"slug": "menu-secondaire-en"
+"term_group": 0
+"term_taxonomy_id": 74
+"parent": 0
+"count": 6
+"filter": "raw"
+"term_order": "0"
}
"footer" => Menu {#7716
+MenuItemClass: "Timber\MenuItem"
+PostClass: "Timber\Post"
+depth: 0
+items: null
+id: null
+ID: null
+term_id: null
+name: null
+title: null
+options: array:1 [
"depth" => 0
]
+raw_options: []
+theme_location: null
+TermClass: "Term"
+object_type: "term"
+_children: null
+taxonomy: null
}
]
]
Super Globals
$_COOKIE
array:1 [
"wp-wpml_current_language" => "en"
]
$_SERVER
array:46 [
"SERVER_SOFTWARE" => "Apache/2.4.56 (Debian)"
"REQUEST_URI" => "/en/lbo-france-announces-its-investment-in-tribvn-healthcare/"
"DOCUMENT_ROOT" => "/var/www/lbofrance.com/docs"
"TMPDIR" => "/tmp"
"TMP" => "/tmp"
"TEMP" => "/tmp"
"PATH" => "/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin"
"HOSTNAME" => "a1c033e8c2ed"
"USER" => "phpuser"
"HOME" => "/var/www"
"SCRIPT_NAME" => "/index.php"
"QUERY_STRING" => ""
"REQUEST_METHOD" => "GET"
"SERVER_PROTOCOL" => "HTTP/1.1"
"GATEWAY_INTERFACE" => "CGI/1.1"
"REDIRECT_URL" => "/en/lbo-france-announces-its-investment-in-tribvn-healthcare/"
"REMOTE_PORT" => "50422"
"SCRIPT_FILENAME" => "/var/www/lbofrance.com/docs/index.php"
"SERVER_ADMIN" => "[no address given]"
"CONTEXT_DOCUMENT_ROOT" => "/var/www/lbofrance.com/docs"
"CONTEXT_PREFIX" => ""
"REQUEST_SCHEME" => "https"
"REMOTE_ADDR" => "34.229.131.158"
"SERVER_PORT" => "443"
"SERVER_ADDR" => "192.168.219.15"
"SERVER_NAME" => "www.lbofrance.com"
"SERVER_SIGNATURE" => "<address>Apache/2.4.56 (Debian) Server at www.lbofrance.com Port 443</address>\n"
"HTTP_CONNECTION" => "Keep-Alive"
"HTTP_HOST" => "www.lbofrance.com"
"HTTP_ACCEPT_ENCODING" => "br,gzip"
"HTTP_IF_MODIFIED_SINCE" => "Sat, 25 Jun 2022 11:53:00 GMT"
"HTTP_ACCEPT_LANGUAGE" => "en-US,en;q=0.5"
"HTTP_ACCEPT" => "text/html,application/xhtml+xml,application/xml;q=0.9,*/*;q=0.8"
"HTTP_USER_AGENT" => "CCBot/2.0 (https://commoncrawl.org/faq/)"
"proxy-nokeepalive" => "1"
"SSL_TLS_SNI" => "www.lbofrance.com"
"HTTPS" => "on"
"HTTP_AUTHORIZATION" => ""
"REDIRECT_STATUS" => "200"
"REDIRECT_SSL_TLS_SNI" => "www.lbofrance.com"
"REDIRECT_HTTPS" => "on"
"REDIRECT_HTTP_AUTHORIZATION" => ""
"FCGI_ROLE" => "RESPONDER"
"PHP_SELF" => "/index.php"
"REQUEST_TIME_FLOAT" => 1685602153.7314
"REQUEST_TIME" => 1685602153
]
